Suppr超能文献

在尿毒症继发性甲状旁腺功能亢进中,不可抑制的甲状旁腺激素分泌与腺体大小有关。

Non-suppressible parathyroid hormone secretion is related to gland size in uremic secondary hyperparathyroidism.

作者信息

Indridason O S, Heath H, Khosla S, Yohay D A, Quarles L D

机构信息

Department of Medicine, Duke University Medical Center, Durham, North Carolina, USA.

出版信息

Kidney Int. 1996 Nov;50(5):1663-71. doi: 10.1038/ki.1996.483.

Abstract

To determine the relative importance of parathyroid gland enlargement and alterations in calcium sensing (set-point changes) in the pathogenesis of uremic secondary hyperparathyroidism (2 degrees HPT), we investigated the relationship between estimates of parathyroid gland size and calcium-mediated parathyroid hormone (PTH) suppression in 19 normocalcemic 2 degrees HPT patients on chronic maintenance hemodialysis. We compared our results to calcium-mediated PTH suppression in 12 normal volunteers, 12 patients with familial benign hypocalciuric hypercalcemia (FBHH), a disorder of abnormal calcium sensing, and 9 subjects with primary hyperparathyroidism (1 degree HPT), which is characterized by both calcium set-point abnormalities and parathyroid gland enlargement. We found that the 2 degrees HPT group displayed a distinctive pattern of calcium-mediated PTH suppression characterized by a failure to normally suppress PTH at supraphysiologic ionized calcium concentrations, similar to 1 degree HPT, but without the rightward shift of the calcium-PTH suppression curve that characterizes calcium sensing abnormalities in FBHH and 1 degree HPT. In the patients with 2 degrees HPT, hypercalcemic suppression resulted in an ending PTH (as a percent of baseline) that was significantly higher (39.8 +/- 4.47%), and a slope of the calcium-PTH suppression curve that was significantly less negative (-4.8 +/- 0.53), compared to respective values of 19.4 +/- 1.81% (P = 0.0009) and -9.0 +/- 1.02 (P = 0.001) in normals and 19.1 +/- 2.49% (P = 0.001) and -9.6 +/- 1.11 (P = 0.0006) in FBHH. Values of ending PTH and slope in 2 degrees HPT patients, however, were similar to those found in 1 degree HPT (49.8 +/- 6.35%, P = 0.21 and -4.5 +/- 0.74, P = 0.72). The ionized calcium concentration required to attain half maximal PTH suppression (EC50) in 2 degrees HPT (1.20 +/- 0.02 mmol/liter) was not significantly different from normals (1.25 +/- 0.01 mmol/liter, P = 0.12) but was significantly less than in 1 degree HPT (1.52 +/- 0.02 mmol/liter, P < 0.0001) and in FBHH (1.44 +/- 0.02 mmol/liter, P < 0.0001). More importantly, we found a significant linear correlation between the natural logarithm of gland size and ending PTH suppression (r = 0.71, P < 0.001) and slope of the calcium-PTH curve (r = 0.67, P = 0.002) in 2 degrees HPT. Thus, calcium non-suppressible PTH secretion in 2 degrees HPT does not represent a simple set-point error, but rather correlates with the degree of parathyroid gland enlargement.

摘要

为了确定甲状旁腺增大和钙敏感受体改变(设定点变化)在尿毒症继发性甲状旁腺功能亢进(2°HPT)发病机制中的相对重要性,我们研究了19例维持性血液透析的正常血钙水平2°HPT患者甲状旁腺大小估计值与钙介导的甲状旁腺激素(PTH)抑制之间的关系。我们将结果与12名正常志愿者、12名家族性良性低钙血症性高钙血症(FBHH,一种钙敏感受体异常的疾病)患者以及9名原发性甲状旁腺功能亢进(1°HPT,其特征为钙设定点异常和甲状旁腺增大)患者的钙介导的PTH抑制情况进行了比较。我们发现,2°HPT组呈现出一种独特的钙介导的PTH抑制模式,其特征为在超生理离子钙浓度下不能正常抑制PTH,这与1°HPT相似,但没有FBHH和1°HPT中表征钙敏感受体异常的钙 - PTH抑制曲线右移。在2°HPT患者中,高钙血症抑制导致的终末PTH(相对于基线的百分比)显著更高(39.8±4.47%),钙 - PTH抑制曲线的斜率显著更平缓(-4.8±y0.53),而正常对照组相应值分别为19.4±1.81%(P = 0.0009)和-9.0±1.02(P = 0.001),FBHH组相应值分别为19.1±2.49%(P = 0.001)和-9.6±1.11(P = 0.0006)。然而,2°HPT患者的终末PTH值和斜率与1°HPT患者相似(49.8±6.35%,P = 0.21和-4.5±0.74,P = 0.72)。2°HPT患者达到半数最大PTH抑制所需的离子钙浓度(EC₅₀)(1.20±0.02 mmol/L)与正常对照组无显著差异(1.25±0.01 mmol/L,P = 0.12),但显著低于1°HPT(1.52±0.02 mmol/L,P < 0.0001)和FBHH(1.44±0.02 mmol/L,P < 0.0001)。更重要的是,我们发现2°HPT患者腺体大小的自然对数与终末PTH抑制(r = 0.71,P < 0.001)以及钙 - PTH曲线斜率(r = 0.67,P = 0.002)之间存在显著的线性相关性。因此,2°HPT中钙不可抑制的PTH分泌并非简单的设定点误差,而是与甲状旁腺增大程度相关。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验